Cano Health EBITDA 2020-2024 | CANOQ

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Cano Health ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Cano Health ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$141.5B
CVS Health (CVS)	$81.4B
Elevance Health (ELV)	$76.8B
Cencora (COR)	$57.6B
DiDi Global (DIDIY)	$25.2B
Natera (NTRA)	$21.6B
Labcorp Holdings (LH)	$20.9B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$13.3B
CochLear (CHEOY)	$13B
Solventum (SOLV)	$12.8B
ICON (ICLR)	$12.1B
Revvity (RVTY)	$11.6B
Viatris (VTRS)	$10.7B
Medpace Holdings (MEDP)	$9.2B
Avantor (AVTR)	$9B
Sonic Healthcare (SKHHY)	$8.8B
HealthEquity (HQY)	$8.4B
Charles River Laboratories (CRL)	$7.8B
Caris Life Sciences,�Inc (CAI)	$7.1B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.8B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.3B
Surgery Partners (SGRY)	$2.9B
Alignment Healthcare (ALHC)	$2.7B
Concentras Parent (CON)	$2.6B
Organon (OGN)	$2.6B
GeneDx Holdings (WGS)	$2.4B
Ardent Health (ARDT)	$2.1B